Market Overview:
The global predictive diagnostics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for personalized medicine, and technological advancements in diagnostic testing. The global predictive diagnostics market is segmented on the basis of type into genetic testing, carrier identification, cancer testing, and others. The genetic testing segment is expected to grow at the highest CAGR during the forecast period owing to increasing demand for early diagnosis and treatment of hereditary disorders. On the basis of application, the global predictive diagnostics market is segmented into hospitals, clinics, and others. The hospitals segment dominates this market owing to rising demand for early diagnosis and treatment of chronic diseases among patients admitted in hospitals.
Product Definition:
The term Predictive Diagnostics refers to the process of predicting the health status of a particular component or system in advance. The importance of Predictive Diagnostics is that it can help identify potential problems before they occur, which can save time and money in terms of maintenance and repairs.
Genetic Testing:
In simple words, genetic testing is the new technology in predictive or diagnostic medicine. It helps doctors and medical practitioners to determine a patient's risk for certain diseases by looking at their genes. This test also helps patients to understand themselves better and also aids in the management of health-related decisions like diet, exercise, stress management etc.
Carrier Identification:
Carrier identification is the process of attributing a cell or group of cells to a specific source. It is an integral part of predictive/preventive diagnostics and involves detecting the presence or absence, strength, and type of any carrier that may be present in blood samples. The information obtained through this technique helps in making accurate disease prognosis and facilitates proper treatment decision making.
Application Insights:
The hospital segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. Predictive diagnostics tests are being increasingly used for various purposes in hospitals, clinics, and other healthcare facilities. These applications include cancer testing, infectious disease testing, cardiovascular disease testing, lung function tests among others. The growing prevalence of chronic diseases such as cancer and cardiovascular diseases coupled with increasing government initiatives to reduce mortality rates is anticipated to drive demand for predictive diagnostic tests over the forecast period.
The others segment includes home healthcare monitoring devices along with laboratory services provided by commercial laboratories or clinical pathology centers at a reduced cost or free of charge depending upon the type of service rendered. Increasing awareness about these services among consumers has resulted in an increased number of test orders being performed through this channel which is expected to have a positive impact on market growth during the estimated time span.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced diagnostic technologies and increasing government initiatives for early disease detection. For instance, as per a recent study published by National Cancer Institute (NCI), in 2016, about 1 million people were diagnosed with cancer each year in U.S., and over 870 thousand people died due to this disease each year making it the leading cause of death among common diseases.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. Predictive diagnostics helps in early diagnosis and treatment of these diseases, which leads to better patient outcomes.
- Growing demand for personalized medicine: There is a growing demand for personalized medicine across the world as patients want treatments that are tailored specifically for them. Predictive diagnostics helps in identifying biomarkers that are unique to each individual, which allows for customized treatment plans.
- Advances in technology: The field of predictive diagnostics is constantly evolving with new technologies being developed all the time. This has led to increased accuracy and efficiency in diagnostic procedures, thus making predictive diagnostics more popular than ever before.
Scope Of The Report
Report Attributes
Report Details
Report Title
Predictive Diagnostics Market Research Report
By Type
Genetic Testing, Carrier Identification, Cancer Testing, Others
By Application
Hospital, Clinic, Others
By Companies
Qiagen, Myriad Genetics, Roche, Genomic Health, LabCorp, Epistem, BioGenex, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Predictive Diagnostics Market Report Segments:
The global Predictive Diagnostics market is segmented on the basis of:
Types
Genetic Testing, Carrier Identification, Cancer Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qiagen
- Myriad Genetics
- Roche
- Genomic Health
- LabCorp
- Epistem
- BioGenex
- Abbott
Highlights of The Predictive Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Genetic Testing
- Carrier Identification
- Cancer Testing
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Predictive Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Predictive diagnostics is a field of medicine that uses data and algorithms to identify patterns in patient health information in order to make predictions about the likelihood of future events. Predictive diagnostics can be used to predict the onset or progression of diseases, identify potential risks for accidents or injuries, and assess whether a person is at risk for developing certain mental illnesses.
Some of the major companies in the predictive diagnostics market are Qiagen, Myriad Genetics, Roche, Genomic Health, LabCorp, Epistem, BioGenex, Abbott.
The predictive diagnostics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Predictive Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Predictive Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Predictive Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Predictive Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Predictive Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Predictive Diagnostics Market Size and Y-o-Y Growth
4.5.2 Predictive Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Predictive Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Predictive Diagnostics Market Size Forecast by Type
5.2.1 Genetic Testing
5.2.2 Carrier Identification
5.2.3 Cancer Testing
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Predictive Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Predictive Diagnostics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Predictive Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Predictive Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Predictive Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Predictive Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Predictive Diagnostics Market Size Forecast by Type
9.6.1 Genetic Testing
9.6.2 Carrier Identification
9.6.3 Cancer Testing
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Predictive Diagnostics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Predictive Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Predictive Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Predictive Diagnostics Market Size Forecast by Type
10.6.1 Genetic Testing
10.6.2 Carrier Identification
10.6.3 Cancer Testing
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Predictive Diagnostics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Predictive Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Predictive Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Predictive Diagnostics Market Size Forecast by Type
11.6.1 Genetic Testing
11.6.2 Carrier Identification
11.6.3 Cancer Testing
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Predictive Diagnostics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Predictive Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Predictive Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Predictive Diagnostics Market Size Forecast by Type
12.6.1 Genetic Testing
12.6.2 Carrier Identification
12.6.3 Cancer Testing
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Predictive Diagnostics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Predictive Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Predictive Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Predictive Diagnostics Market Size Forecast by Type
13.6.1 Genetic Testing
13.6.2 Carrier Identification
13.6.3 Cancer Testing
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Predictive Diagnostics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Predictive Diagnostics Market: Competitive Dashboard
14.2 Global Predictive Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Qiagen
14.3.2 Myriad Genetics
14.3.3 Roche
14.3.4 Genomic Health
14.3.5 LabCorp
14.3.6 Epistem
14.3.7 BioGenex
14.3.8 Abbott
